Compounds having the formula (I), and enantiomers, and diastereomers, pharmaceutically-acceptable salts, thereof, (I) are useful as kinase modulators, including Btk modulation, wherein A
1
, A
2
, A
3
, R
4
are as defined herein.
Compounds having the formula (I), and enantiomers, and diastereomers, pharmaceutically-acceptable salts, thereof, (I) are useful as kinase modulators, including Btk modulation, wherein A1, A2, A3, R4 are as defined herein.
Azaindazoles as Btk kinase modulators and use thereof
申请人:Bristol-Myers Squibb Company
公开号:EP2789614A1
公开(公告)日:2014-10-15
Compounds having the formula (I), and enantiomers, and diastereomers, pharmaceutically-acceptable salts, thereof,
are useful as kinase modulators, including Btk modulation, wherein A1, A2, A3, R4, are as defined herein.